肾脏免疫学的分子方面：现状与未来展望。
Molecular Aspects of Renal Immunology: Current Status and Future Perspectives.
机构信息
Department of Nephrology, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece.
Nephrology Department, Institut Hospital del Mar d'Investigacions Mèdiques, Hospital del Mar, Parc de Salut Mar, 08003 Barcelona, Spain.
出版信息
Int J Mol Sci. 2022 Apr 6;23(7):4040. doi: 10.3390/ijms23074040.
Abstract
Kidney transplantation is the most promising treatment available for patients with end-stage kidney disease [...].
摘要
肾移植是终末期肾病患者最有前途的治疗方法[...]。
相似文献
1
Molecular Aspects of Renal Immunology: Current Status and Future Perspectives.肾脏免疫学的分子方面：现状与未来展望。
Int J Mol Sci. 2022 Apr 6;23(7):4040. doi: 10.3390/ijms23074040.
2
[Present status and perspectives of kidney transplantation].[肾移植的现状与展望]
Z Gesamte Inn Med. 1986 May 15;41(10):294-7.
3
Treatment of end stage renal disease in Rhode Island: a status report.罗德岛末期肾病的治疗：一份现状报告。
R I Med J (1974). 1975 Apr;58(4):151-5, 168-9.
4
Kidney Disease in Oman: a View of the Current and Future Landscapes.阿曼的肾脏疾病：当前与未来形势展望
Iran J Kidney Dis. 2017 Jul;11(4):263-270.
5
[The future of life support measures in terminal renal failure].[终末期肾衰竭生命支持措施的未来]
Schweiz Rundsch Med Prax. 1986 Feb 25;75(9):211-2.
6
Robotic kidney transplantation: current status and future perspectives.机器人辅助肾移植：现状与未来展望。
Minerva Urol Nefrol. 2017 Feb;69(1):5-13. doi: 10.23736/S0393-2249.16.02856-3. Epub 2016 Nov 30.
7
[Future challenges for the care and treatment of kidney disease].[肾脏疾病护理与治疗的未来挑战]
Duodecim. 2006;122(2):193-5.
8
[Chronic hemodialysis in Belgium. Perspectives for the next 5 years].[比利时的慢性血液透析。未来5年的展望]
Acta Clin Belg. 1974;29(4):212-7.
9
Future trends of management of renal failure in diabetics.糖尿病患者肾衰竭管理的未来趋势
Kidney Int Suppl. 1993 Jun;41:S8-13.
10
Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair.肾脏移植、生物工程与再生：一门原本基于免疫学的学科，注定要向特制器官制造与修复方向转变。
Expert Rev Clin Immunol. 2016;12(2):169-82. doi: 10.1586/1744666X.2016.1112268. Epub 2015 Dec 4.
引用本文的文献
1
A new era in the treatment of kidney diseases: NLRP3 inflammasome and cytokine-targeted therapies.肾脏病治疗的新时代：NLRP3炎性小体和细胞因子靶向疗法。
Pediatr Nephrol. 2025 May;40(5):1515-1521. doi: 10.1007/s00467-024-06578-0. Epub 2024 Nov 1.
本文引用的文献
1
The Endothelial Glycocalyx as a Target of Ischemia and Reperfusion Injury in Kidney Transplantation-Where Have We Gone So Far?内皮糖萼作为肾移植中缺血再灌注损伤的靶点：我们已经走了多远？
Int J Mol Sci. 2021 Feb 22;22(4):2157. doi: 10.3390/ijms22042157.
2
A Role for Human Renal Tubular Epithelial Cells in Direct Allo-Recognition by CD4+ T-Cells and the Effect of Ischemia-Reperfusion.人肾近端小管上皮细胞在 CD4+T 细胞直接同种异体识别中的作用及其缺血再灌注的影响。
Int J Mol Sci. 2021 Feb 9;22(4):1733. doi: 10.3390/ijms22041733.
3
Review: Ischemia Reperfusion Injury-A Translational Perspective in Organ Transplantation.综述：器官移植中的缺血再灌注损伤——转化视角。
Int J Mol Sci. 2020 Nov 13;21(22):8549. doi: 10.3390/ijms21228549.
4
T cell Allorecognition Pathways in Solid Organ Transplantation.实体器官移植中的 T 细胞同种异体识别途径。
Front Immunol. 2018 Nov 5;9:2548. doi: 10.3389/fimmu.2018.02548. eCollection 2018.
5
Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board.肾移植的最新进展：笛卡尔顾问委员会的观点。
Nephrol Dial Transplant. 2018 Oct 1;33(10):1699-1707. doi: 10.1093/ndt/gfx365.
6
Delayed graft function and the risk of acute rejection in the modern era of kidney transplantation.移植肾功能延迟恢复与现代肾移植时代的急性排斥反应风险
Kidney Int. 2015 Oct;88(4):851-8. doi: 10.1038/ki.2015.190. Epub 2015 Jun 24.
7
Renal allograft fibrosis: biology and therapeutic targets.肾移植纤维化：生物学和治疗靶点。
Am J Transplant. 2015 Apr;15(4):863-86. doi: 10.1111/ajt.13180. Epub 2015 Feb 17.
8
A microscopic view on the renal endothelial glycocalyx.肾内皮糖萼的微观视图。
Am J Physiol Renal Physiol. 2015 May 1;308(9):F956-66. doi: 10.1152/ajprenal.00532.2014. Epub 2015 Feb 11.
9
The renal endothelium in diabetic nephropathy.糖尿病肾病中的肾脏内皮细胞。
Ren Fail. 2013;35(4):592-9. doi: 10.3109/0886022X.2013.773836. Epub 2013 Mar 11.
Zotero 插件